CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 321 enrolled
Drug / intervention
Anti-Arrhythmic therapy +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02459574
NCT02459574N/ACompleted
CompareCT.gov

Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation

Imperial College London·interventional·Posted Jun 2, 2015·Updated Oct 9, 2024

In Brief

A clinical study evaluating AVATAR-AF ablation, Anti-Arrhythmic therapy, and 1 other intervention for Heart Failure and Recurrent Atrial Fibrillation. Completed, enrolled 321 participants across 13 sites.

Detailed Summary

A streamlined AF ablation procedure done without PV mapping as a daycase is more effective than anti-arrhythmic drugs at reducing all hospital episodes for recurrent atrial fibrillation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Recurrent Atrial Fibrillation
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2, 2015
Enrollment StartMay 1, 2015
Primary CompletionSep 30, 2018
Study CompletionNov 27, 2018
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 11.1 years ago

Interventions

AVATAR-AF ablationprocedure

Experimental ablation protocol

Anti-Arrhythmic therapydrug

Group 2 will be prescribed medication listed below: Amiodarone; Dronaderone; Sotalol Beta blockers; Calcium channel blockers; Flecainide; or Propafenone. You will then be discharged from clinic. A research nurse will contact you by phone to make sure there are no problems and can make hospital appointments if needed.

Conventional AF ablationprocedure

Conventional ablation procedure